Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:82503265:5557 |
Source | marc_columbia |
Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:82503265:5557?format=raw |
LEADER: 05557mam a2200385 a 4500
001 4064663
005 20221027030337.0
008 001027t20012001nyua b 001 0 eng c
010 $a 00050851
020 $a1888799307 (hard : alk. paper)
035 $a(OCoLC)ocm45276834
035 $9ASS2914HS
035 $a4064663
040 $aNLM$cNLM$dNNC-M$dOrLoB-B
042 $apcc
060 10 $aWL 385$bP3795 2001
069 0 $a100969354
245 00 $aPediatric epilepsy :$bdiagnosis and therapy /$cJohn M. Pellock, W. Edwin Dodson, Blaise F.D. Bourgeois, editors.
250 $a2nd ed.
260 $aNew York :$bDEMOS,$c[2001], ©2001.
300 $axv, 666 pages :$billustrations ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tPathophysiology of Seizures and Epilepsy in the Immature Brain: Cells, Synapses, and Circuits /$rLibor Velisek and Solomon L. Moshe --$g2.$tIon Channels, Membranes, and Molecules in Epilepsy and Neuronal Excitability /$rRobert J. DeLorenzo --$g3.$tMetabolic and Pharmacologic Consequences of Seizures /$rMichael V. Johnston and John W. McDonald --$g4.$tThe Pathology of the Epilepsies: Insights from Pathology to Mechanisms of Causation of Temporal Lobe Epilepsy /$rNihal C. de Lanerolle --$g5.$tGenetic Influences on Risk for Epilepsy /$rRuth Ottman --$g6.$tClassification of Epilepsies in Childhood /$rFritz E. Dreifuss and Douglas R. Norddi, Jr. --$g7.$tEpidemiology of Epilepsy in Children /$rW. Allen Hauser --$g8.$tAn Approach to the Child with Paroxysmal Phenomena with Emphasis on Nonepileptic Disorders /$rArthur L. Prensky --$g9.$tThe Use of Electroencephalography in the Diagnosis of Epilepsy in Childhood /$rDouglas R. Nordli, Jr. and Timothy A. Pedley --
505 80 $g10.$tNeuroimaging in Pediatric Epilepsy /$rRuben I. Kuzniecky --$g11.$tNeonatal Seizures /$rEli M. Mizrahi and Peter Kellaway --$g12.$tFebrile Seizures /$rN. Paul Rosman --$g13.$tSevere Encephalopathic Epilepsy in Infants: West Syndrome /$rShunsuke Ohtahara and Yasuko Yamatogi --$g14.$tSevere Encephalopathic Epilepsy in Early Infancy /$rShunsuke Ohtahara and Yasuko Yamatogi --$g15.$tEncephalopathic Epilepsy after Infancy /$rTracy A. Glauser and Diego A. Morita --$g16.$tAbsence Seizures /$rPhillip L. Pearl and Gregory L. Holmes --$g17.$tProgressive Myoclonus Epilepsies /$rSamuel F. Berkovic --$g18.$tLocalization-Related Epilepsies: Simple Partial Seizures, Complex Partial Seizures, Benign Focal Epilepsy of Childhood, and Epilepsia Partialis Continua /$rG. Arunkumar, Prakash Kotagal and A. David Rothner --$g19.$tSelected Disorders Associated with Epilepsy /$rEdwin C. Myer and Lawrence D. Morton --$g20.$tStatus Epilepticus /$rDavid J. Leszczyszyn and John M. Pellock --
505 80 $g21.$tTreatment Decisions in Childhood Seizures /$rShlomo Shinnar and Christine O'Dell --$g22.$tComparative Anticonvulsant Profiles and Proposed Mechanisms of Action of the Established and Newer Antiepileptic Drugs /$rH. Steve White --$g23.$tPharmacokinetic Principles of Antiepileptic Therapy in Children /$rW. Edwin Dodson --$g24.$tDosage Form Considerations in the Treatment of Pediatric Epilepsy /$rWilliam R. Garnett and James C. Cloyd --$g25.$tAdverse Effects of Antiepileptic Drugs /$rL. James Willmore, James W. Wheless and John M. Pellock --$g26.$tTeratogenicity of Anticonvulsant Medication /$rMark S. Yerby --$g27.$tBenzodiazepines /$rKevin Farrell --$g28.$tBarbiturates and Primidone /$rRobert S. Rust --$g29.$tPhenytoin and Related Drugs /$rW. Edwin Dodson --$g30.$tCarbamazepine and Oxcarbazepine /$rW. Edwin Dodson --$g31.$tValproate /$rBlaise F. D. Bourgeois --$g32.$tClinical Use of Ethosuximide, Methsuximide, and Trimethadione /$rSanford Schneider --
505 80 $g33.$tGabapentin /$rGregory L. Holmes and Phillip L. Pearl --$g34.$tLamotrigine /$rJohn M. Pellock --$g35.$tFelbamate /$rBlaise F. D. Bourgeois --$g36.$tTopiramate /$rTracy A. Glauser --$g37.$tTiagabine /$rShlomo Shinnar and Kenneth W. Sommerville --$g38.$tVigabatrin /$rGunter Kramer --$g39.$tZonisamide /$rRobert S. Fisher, John F. Kerrigan and John M. Pellock --$g40.$tOther New Antiepileptic Drugs /$rRobert S. Fisher and John F. Kerrigan --$g41.$tACTH and Steroids /$rKatherine M. Martien and O. Carter Snead --$g42.$tVitamins, Dietary Considerations, and Alternative Antiepileptic Drugs /$rPhilip H. Sheridan --$g43.$tThe Ketogenic Diet /$rDouglas R. Nordli, Jr. and Darryl C. De Vivo --$g44.$tDrug Interactions /$rJamie T. Gilman --$g45.$tCombination Drug Therapy (Monotherapy Versus Polytherapy) /$rBlaise F. D. Bourgeois --$g46.$tCosts of Pediatric Epilepsy /$rJohn F. Annegers and Charles E. Begley --$g47.$tSurgical Evaluation /$rMichael Duchowny --
505 80 $g48.$tSurgical Treatment: Surgery and Outcome /$rJeffrey G. Ojemann and T. S. Park --$g49.$tQuality of Life in Children with Epilepsy /$rJoan K. Austin and Nancy Santilli --$g50.$tEpilepsy, Cerebral Palsy, and IQ /$rW. Edwin Dodson --$g51.$tCognitive Side Effects of Antiepileptic Drugs /$rAlbert P. Aldenkamp and Jan Vermeulen.
650 12 $aEpilepsy$xdiagnosis.$0https://id.nlm.nih.gov/mesh/D004827Q000175
650 22 $aEpilepsy$xtherapy.$0https://id.nlm.nih.gov/mesh/D004827Q000628
700 1 $aPellock, John M.$0http://id.loc.gov/authorities/names/n83151212
700 1 $aDodson, W. Edwin.$0http://id.loc.gov/authorities/names/n90705896
700 1 $aBourgeois, Blaise F. D.$0http://id.loc.gov/authorities/names/n00123390
852 00 $boff,hsl$hRJ496.E6$iP43 2001 Q